kabutan

SANTEN PHARMACEUTICAL CO.,LTD.(4536) Summary

4536
TSE Prime
SANTEN PHARMACEUTICAL CO.,LTD.
1,558.5
JPY
-20.5
(-1.30%)
Dec 12, 3:30 pm JST
10.00
USD
Dec 12, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
14.7
PBR
1.82
Yield
2.44%
Margin Trading Ratio
18.85
Stock Price
Dec 12, 2025
Opening Dec 12, 9:00 am
1,588.5 JPY 10.21 USD
Previous Close Dec 11
1,579.0 JPY 10.11 USD
High Dec 12, 9:02 am
1,600.0 JPY 10.29 USD
Low Dec 12, 1:27 pm
1,555.5 JPY 9.98 USD
Volume
1,044,100
Trading Value
1.64B JPY 0.01B USD
VWAP
1568.16 JPY 10.07 USD
Minimum Trading Value
155,850 JPY 1,000 USD
Market Cap
0.50T JPY 3.24B USD
Number of Trades
2,179
Liquidity & Number of Trades
As of Dec 12, 2025
Liquidity
High
1-Year Average
2,687
1-Year High Aug 8, 2025
10,497
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 5, 2025 31,600 220,100 6.97
Nov 28, 2025 34,000 218,300 6.42
Nov 21, 2025 72,700 213,300 2.93
Nov 14, 2025 73,400 220,000 3.00
Nov 7, 2025 73,900 237,600 3.22
Company Profile
SANTEN PHARMACEUTICAL CO., LTD. is a leading manufacturer of ophthalmic pharmaceuticals. Its flagship product is the over-the-counter eye drop brand "Sante". The company is strengthening its global expansion.
Sector
Pharmaceuticals
SANTEN PHARMACEUTICAL CO., LTD. primarily focuses on prescription pharmaceuticals, while also engaging in the research, development, manufacturing, and sales of over-the-counter drugs and medical devices. The company specializes in ophthalmology products. It operates globally, with a presence in Japan, China, Asia, Europe, the Middle East, Africa, North America, and other regions worldwide, forming a global corporate group. The overseas sales ratio accounts for approximately 40% of total revenue. The group consists of SANTEN PHARMACEUTICAL CO., LTD., 34 consolidated subsidiaries, and 2 equity-method affiliates. With numerous subsidiaries across the globe, the group implements business strategies tailored to the market characteristics of each region.